|
Screening of Healthy Volunteers for Clinical Trials of Vaccines to Prevent Infectious Diseases Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about Screening of Healthy Volunteers for Clinical Trials of Vaccines to Prevent Infectious Diseases conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Screening of Healthy Volunteers for Clinical Trials of Vaccines to Prevent Infectious Diseases Clinical research trials and Screening of Healthy Volunteers for Clinical Trials of Vaccines to Prevent Infectious Diseases health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including Screening of Healthy Volunteers for Clinical Trials of Vaccines to Prevent Infectious Diseases. Screening of Healthy Volunteers for Clinical Trials of Vaccines to Prevent Infectious Diseases Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Screening of Healthy Volunteers for Clinical Trials of Vaccines to Prevent Infectious Diseases clinical trial. Test subjects typically receive the most expert healthcare available for their Screening of Healthy Volunteers for Clinical Trials of Vaccines to Prevent Infectious Diseases condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Screening of Healthy Volunteers for Clinical Trials of Vaccines to Prevent Infectious Diseases Screening of Healthy Volunteers for Clinical Trials of Vaccines to Prevent Infectious Diseases
Screening of Healthy Volunteers for Clinical Trials of Vaccines to Prevent Infectious Diseases
For Condition: Healthy
Status: Recruiting
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: This protocol will screen healthy normal volunteers for participation in studies of vaccines under development at NIAID's Vaccine Research Center. Of interest are vaccines for: - Newly identified infectious diseases such as SARS. - Infectious diseases of concern as possible bioweapons, such as smallpox and Ebola virus - Emerging infectious diseases that are more widespread geographically than in the past, such as West Nile virus - For preventing diseases such as tuberculosis and malaria. Healthy normal volunteers between 18 and 60 years of age may be eligible for this protocol. Screening begins about 1 to 6 months before the start of the vaccine study. Participants will have a physical examination and health history, including questions about sexual activity and drug use. Over the course of the screening visits, participants will be asked to give urine and blood samples to test for various infections and other medical problems. Women capable of getting pregnant will be given a pregnancy test. Women who are pregnant or breastfeeding will not be enrolled in the study. At the end of the screening, participants will be informed about which vaccines are currently being tested in clinical trials for which they may be eligible. Once participants enroll in a vaccine study, their participation in the screening protocol ends.
Details: The purpose of the study is to screen potential study volunteers to determine if they are eligible for Phase I infectious disease vaccine clinical trials being sponsored by the Vaccine Research Center at the National Institutes of Health. Educational materials on vaccines will be reviewed with and provided to subjects before enrollment into the study.
Eligibility:
Study Type: Observational, Screening
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Age: 18 to 60 years of age Willing to participate for the planned duration of the study (6 months or longer) Able and willing to complete the informed consent process Agree to have blood stored for future studies of the vaccine, the immune system, and/or other medical conditions EXCLUSION CRITERIA: Known to be HIV-infected (Seropositive) As condition requiring medication that affects the immune response to a vaccine such as oral and parenteral corticosteroids, hydroxyurea, interleukin-2 or other immune modulators A condition in which repeated blood draws or injections pose more than minimal risk for the subject such as hemophilia, other severe coagulation disorders or significantly impaired venous access A condition that requires active medical intervention or monitoring to avert serious danger to the participant's health or well-being A condition in which signs or symptoms could be confused with reactions to vaccine Active participation in other experimental treatment studies Pregnancy or breast-feeding
Total Enrollment: 1000
Location and Contact Information:
National Institute of Allergy and Infectious Diseases (NIAID) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 030285; 03-I-0285
Study Start Date: September 3, 2003
Record last reviewed: August 22, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00068926
Other Healthy Studies:
1. The Impact of Familiarity and Emotional Attachment on the Visual Processing of Faces
2. Bone Mineral Density in Women with Major Depression
3. Comparison of Externally and Self-Initiated Movements
4. Treatment of Non-Tuberculous Mycobacterial Infections with Interferon Gamma
5. Study of the Hypothalmic-Pituitary-Adrenal (HPA) Axis and its Role in Major Depression
Related Studies:
Other Healthy Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Screening of Healthy Volunteers for Clinical Trials of Vaccines to Prevent Infectious Diseases
|
|
|
|
|
|
|
|